As used in the Wholesale Prescription Drug Importation Act: A. "Canadian supplier" means a manufacturer, wholesale distributor or pharmacy that is appropriately licensed or permitted under Canadian federal or provincial laws and rules to manufacture, distribute or dispense prescription drugs; B. "committee" means the prescription drug importation advisory committee; C. "department" or "authority" means the health care authority department; D. "eligible prescription drug" means a drug eligible for importation that: (1) meets the United States food and drug administration's standards related to safety, effectiveness, misbranding and adulteration; (2) does not violate federal patent laws; (3) is expected to generate cost savings; and (4) is not a controlled substance; E. "program" means the wholesale prescription drug importation program; and F. "state drug wholesaler" means a licensed wholesale drug distributor that contracts with the state to import eligible prescription drugs from a Canadian supplier. History: Laws 2020, ch. 45, § 2; 2024, ch. 39, § 58. The 2024 amendment, effective July 1, 2024, in Subsection C, after "'department'" added "or authority", after "means the" deleted "department of", and after "health" added "care authority department".
‹ Prev All New Mexico sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.